» Articles » PMID: 33473203

Pathophysiology of Sepsis-induced Cardiomyopathy

Overview
Journal Nat Rev Cardiol
Date 2021 Jan 21
PMID 33473203
Citations 211
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis is the life-threatening organ dysfunction caused by a dysregulated host response to infection and is the leading cause of death in intensive care units. Cardiac dysfunction caused by sepsis, usually termed sepsis-induced cardiomyopathy, is common and has long been a subject of interest. In this Review, we explore the definition, epidemiology, diagnosis and pathophysiology of septic cardiomyopathy, with an emphasis on how best to interpret this condition in the clinical context. Advances in diagnostic techniques have increased the sensitivity of detection of myocardial abnormalities but have posed challenges in linking those abnormalities to therapeutic strategies and relevant clinical outcomes. Sophisticated methodologies have elucidated various pathophysiological mechanisms but the extent to which these are adaptive responses is yet to be definitively answered. Although the indications for monitoring and treating septic cardiomyopathy are clinical and directed towards restoring tissue perfusion, a better understanding of the course and implications of septic cardiomyopathy can help to optimize interventions and improve clinical outcomes.

Citing Articles

Impact of left ventricular stroke work index on 30-day mortality in sepsis: a retrospective analysis based on the MIMIC-III database.

Li Y, Li Z, Bu S, Wang Q, Zeng Q, Lin W BMC Infect Dis. 2025; 25(1):334.

PMID: 40065224 PMC: 11892311. DOI: 10.1186/s12879-025-10723-x.


New developments in the role of ferroptosis in sepsis‑induced cardiomyopathy (Review).

Wang D, Qu X, Zhang Z, Zhou G Mol Med Rep. 2025; 31(5).

PMID: 40052561 PMC: 11904766. DOI: 10.3892/mmr.2025.13483.


Caveolin and oxidative stress in cardiac pathology.

Zadorozny L, Du J, Supanekar N, Annamalai K, Yu Q, Wang M Front Physiol. 2025; 16:1550647.

PMID: 40041164 PMC: 11876135. DOI: 10.3389/fphys.2025.1550647.


NLRP3 Inflammasome Targeting Offers a Novel Therapeutic Paradigm for Sepsis-Induced Myocardial Injury.

Jin Y, Fleishman J, Ma Y, Jing X, Guo Q, Shang W Drug Des Devel Ther. 2025; 19:1025-1041.

PMID: 39967903 PMC: 11834678. DOI: 10.2147/DDDT.S506537.


Septic Cardiomyopathy: Difficult Definition, Challenging Diagnosis, Unclear Treatment.

Zakynthinos G, Giamouzis G, Xanthopoulos A, Oikonomou E, Kalogeras K, Karavidas N J Clin Med. 2025; 14(3).

PMID: 39941657 PMC: 11818464. DOI: 10.3390/jcm14030986.


References
1.
Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

2.
Parker M, Shelhamer J, Bacharach S, Green M, Natanson C, Frederick T . Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984; 100(4):483-90. DOI: 10.7326/0003-4819-100-4-483. View

3.
Cunnion R, Schaer G, Parker M, Natanson C, Parrillo J . The coronary circulation in human septic shock. Circulation. 1986; 73(4):637-44. DOI: 10.1161/01.cir.73.4.637. View

4.
Walkey A, Wiener R, Ghobrial J, Curtis L, Benjamin E . Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011; 306(20):2248-54. PMC: 3408087. DOI: 10.1001/jama.2011.1615. View

5.
Werdan K, Schmidt H, Ebelt H, Zorn-Pauly K, Koidl B, Hoke R . Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol. 2009; 87(4):266-74. DOI: 10.1139/Y09-012. View